Results 131 to 140 of about 8,148 (212)

Pelajar Pascasiswazah ke negeri Cik Siti Wan Kembang bagi melestarikan warisan seni budaya rakyat Malaysia / Nor Eeda Ali

Seri Iskandar, 02 Jun 2024 – Pusat Pengajian Siswazah, Universiti Teknologi MARA (UiTM) Cawangan Perak telah menganjurkan lawatan ke Negeri Cik Siti Wan Kembang bersama-sama ahli PEWANI UiTM Cawangan Perak pada 31 Mei 2024 hingga 02 Jun 2024. Program ini
Ali, Nor Eeda
core  

Therapeutic Potential of CAR-CIK Cells in Acute Leukemia Relapsed Post Allogeneic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Canichella M, de Fabritiis P, Abruzzese E.   +2 more
europepmc   +1 more source

Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. [PDF]

Sci Rep
Li S, Qin J, Sun Q, Zhao H, Xiong Y, Wang Y, Han Y, Zhang J, Zhang W, Shen M, Yang F, Ren B, Zhou L, Li R, Hui Z, Tian X, Cao S, Du W, Yu W, Liu L, Zhang X, Ren X.   +21 more
europepmc   +1 more source

From bench to bedside: advances in cell therapy for tuberculosis treatment. [PDF]

Stem Cell Res Ther
Chunxiao L, Junsheng F, Xuerong C, Xiaomin W, Shuihua L.   +4 more
europepmc   +1 more source

Synergistic antitumor efficacy of CIK cells combined with PD-1 inhibitors in nasopharyngeal carcinoma. [PDF]

Am J Transl Res
Chen J, Sailihan T, Chen Y, Xv S, Qian J, Shen X, Yang H, Zhang P.   +7 more
europepmc   +1 more source

CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy. [PDF]

Front Oncol
Chen P, Pan J, Chen L, Feng X.
europepmc   +1 more source

Overcoming heterogeneity and immunosuppression: novel strategies in adoptive therapy for biliary tract cancer. [PDF]

Front Immunol
Zhu Y, Xiong G, Guan M, Sun D, Guo Y, Peng J, Zhu H.   +6 more
europepmc   +1 more source

Evaluating patient-reported outcomes in randomized controlled trials of targeted therapy and/or immunotherapy for liver cancer: a scoping review. [PDF]

Front Oncol
Ren L, Liu Y, Li S, Yue S, Su C, Wang J, Zhang Y.   +6 more
europepmc   +1 more source

DEAD-box helicase gcDDX56 disrupts IRF3 nuclear import complex and promotes nuclear IRF3 degradation for enhancing GCRV replication. [PDF]

J Virol
Xiao LL, Chen Y, Zhang J, Xiao J, Feng H, Chang MX.   +5 more
europepmc   +1 more source

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review. [PDF]

Breast Cancer (Dove Med Press)
Abbaspour M, Esmaeil N, Akbari V, Ghoreishi M, Rafiepoor H.   +4 more
europepmc   +1 more source